Efficacy of Amino Acid Chelated Iron versus Ferrous Fumarate in Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial
Fekry Abd El-menem Fekry;
Abstract
The study was done through giving anaemic pregnant women iron therapy in the form of ferrous fumarate which represents group A arid amino acid chelated iron and it represents Group B.
For each pregnant woman, age, parity and gestational history were taken before treatment. All pregnant women took their allocated treatment regularly for eight weeks after diagnosis of iron deficiency anemia with hemoglobin level and serum ferritin level and followed up after four and eight weeks. Also, epigastric pain, diarrhea, constipation, nausea, vomiting or gastric distress reported to assess tolerability of the drugs.
Key words: Haematocrite value- Hemojuvelin- Iron deficiency anaemia- Hephaestin- Lacto ferrin
For each pregnant woman, age, parity and gestational history were taken before treatment. All pregnant women took their allocated treatment regularly for eight weeks after diagnosis of iron deficiency anemia with hemoglobin level and serum ferritin level and followed up after four and eight weeks. Also, epigastric pain, diarrhea, constipation, nausea, vomiting or gastric distress reported to assess tolerability of the drugs.
Key words: Haematocrite value- Hemojuvelin- Iron deficiency anaemia- Hephaestin- Lacto ferrin
Other data
| Title | Efficacy of Amino Acid Chelated Iron versus Ferrous Fumarate in Treatment of Iron Deficiency Anemia in Pregnancy: A Randomized Controlled Trial | Other Titles | فعالية وقابلية التحمل لمركبات الحديد المتصلة بالأحماض الأمينية بالمقارنة مع فيومارات الحديد التقليدية في علاج مرض فقر الدم الناتج عن نقص الحديد لدي النساء الحوامل | Authors | Fekry Abd El-menem Fekry | Issue Date | 2016 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.